Biocon Q3FY22 revenue at Rs 2,223 crore, up by 18%
Biocon, a global biopharmaceuticals company, announced its consolidated financial results for the third quarter ended December 31, 2021, on Thursday...
Begin typing your search...
Pharma
Glenmark Pharma gets USFDA nod for nasal spray, Ryaltris
Glenmark Pharmaceuticals on Friday said its subsidiary has received approval from the US health regulator to market Ryaltris, a nasal spray for the...
UPI-like digital healthcare interface to go live this week
UHI has the potential to transform India’s health ecosystem with interoperability of health services
ICMR bars Molnupiravir in Covid-19 clinical protocol
National Task forece cited safety reasons that Molnupiravir was not of much benefit in Covid treatment
Alembic Pharma gets tentative USFDA approval for generic Vortioxetine...
Alembic Pharmaceuticals Ltd said it has received tentative approval from the US health regulator for its generic Vortioxetine tablets indicated for...
Aurobindo's Molnaflu for Covid treatment
Aurobindo Pharma Limited has made its brand of molnupiravir- Molnaflu available widely in India.
MSN's Molulow 200 mg caps for Covid
City-based MSN Group, is all set to launch the generic molnupiravir 200 mg capsules for treating Covid-19 under the brand name Molulow.
Indian pharma sector expected to grow 9-11% in FY22: ICRA
India's pharma sector is expected to grow at 9-11 per cent in FY22, rating agency ICRA said on Tuesday.
